Presenter Biography

Luk H. Vandenberghe, Ph.D.

Massachusetts Eye and Ear Infirmary and Harvard Medical School

Luk H. Vandenberghe, Ph.D., directs the Ocular Gene Transfer Core at the Massachusetts Eye and Ear Infirmary and Harvard Medical School. He is a member of the Ocular Genomics Institute, the Berman Gund laboratory and the Harvard Stem Cell Institute at Harvard. Dr. Vandenberghe is the recipient of numerous prizes and awards and has published in excess of 40 peer-reviewed research articles and created more than a dozen patents related to gene transfer and therapy. He is a co-founder of GenSight Biologics, a biotech company focused on innovative gene therapies for blinding disorders. The research mission of Dr. Vandenberghe’s laboratory is to develop gene therapy as a broadly applicable treatment in ophthalmology through the study and development of technologies that overcome current translational hurdles.

Keynote Speaker

• Michael Hingson, The Michael Hingson Group, Inc.

Presenters

• Isabelle Audo, M.D., PH.D., Quinze-Vingts Hospital
• Benjamin Bakall, Ph.D., University of Iowa
• William Beltran, D.V.M., Ph.D., School of Veterinary Medicine
• Eliot Berson, Massachusetts Eye and Ear Infirmary
• Kathy Blake
• Shannon Boye, University of Florida
• Rusty Bromley, Translational Research Acceleration via Consulting
• Tiffany Chan, O.D., Wilmer Eye Institute, Johns Hopkins University
• Charlie Collins, Vision Dynamics, LLC
• Stephen Daiger, University of Texas Health Science Center in Houston
• Arlene Drack
• Jacque L. Duncan, M.D., University of California, San Francisco
• Timothy Elder, TRE Legal Practice, LLC
• Gerald Fishman, M.D., The Chicago Lighthouse for People Who are Blind or Visually Impaired
• David M. Gamm, M.D., Ph.D., University of Wisconsin-Madison
• Duane R. Geruschat, Ph.D., Salus University
• Douglas Goist, National Industries for the Blind
• Michael Grassi
• James T. Handa, M.D., Wilmer Eye Institute, Johns Hopkins University
• Rod Haneline, Leader Dogs for the Blind
• Brian Hurley, National Industries for the Blind
• Christine Kay, M.D., University of Florida
• Mark E. Kleinman, M.D.
• Craig MacFarlane, Edward Jones Company
• Toni March, Office of Blindness and Vision Services, Division of Rehabilitation Services
• Michel Michaelides
• Muna Naash
• Mark Pennesi, M.D., Ph.D., Casey Eye Institute
• Darlene Peregoy, Office for Blindness and Vision Services, Division of Rehabilitation Services
• Eric Pierce, Massachusetts Eye and Ear Infirmary
• Dan Roberts, Macular Degeneration Support
• José-Alain Sahel, M.D.
• Philip Saunders
• Hendrik Scholl
• Everett T. Shupe II, MBA, CAE, CMP, Shupe Plans
• Janet Sunness, M.D., Hoover Low Vision Rehabilitation Services, Greater Baltimore Medical Center
• Karmen M Trzupek, MS, CGC, Informed Medical Decisions, Inc.
• Dawn E. Turco, Hadley School for the Blind
• Lou Tutt, Association for Education and Rehabilitation of the Blind and Visually Impaired
• Luk H. Vandenberghe, Ph.D., HMassachusetts Eye and Ear Infirmary and Harvard Medical School
• Douglas Walker, Hadley School for the Blind
• Richard G. Weleber, M.D., Casey Eye Institute, Oregon Health and Science University
• Dan Wenzel, Blind Industries and Services of Maryland
• Kim Walker, Tennessee School for the Blind
• Sandy White, Blind Sports Organization
• Paul Yang, M.D., Ph.D., University of Utah
• Donald Zack
• Michael Zuber